• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ultrastructural and immunogenic changes in the formation of mycetoma grains.

作者信息

Wethered D B, Markey M A, Hay R J, Mahgoub E S, Gumaa S A

出版信息

J Med Vet Mycol. 1987 Feb;25(1):39-46. doi: 10.1080/02681218780000051.

DOI:10.1080/02681218780000051
PMID:2437279
Abstract

The differences in the fine structure and antigenic determinants of mycetoma fungi in the mycelial phase in vitro and in grains in vivo facilitate an interpretation of grain formation. Aggregates of hyphal elements with multiple and thickened walls was a feature of the fungi in vivo. Associated with hyphal wall material, numerous polysaccharide microfibrils were detected in grains of Madurella mycetomatis. These were not seen associated with hyphal elements in vitro and it is suggested that these structures may be concerned with the aggregation of fungal elements in the formation of grains. Antibodies directed against the fungi in vitro were shown, by indirect immunogold labelling, to bind at identical sites in fungal material grown in vitro as in mycetoma grains. However the grain matrix was not labelled, suggesting that part of the structure formed in vivo is composed of modified antigen or is host derived.

摘要

相似文献

1
Ultrastructural and immunogenic changes in the formation of mycetoma grains.
J Med Vet Mycol. 1987 Feb;25(1):39-46. doi: 10.1080/02681218780000051.
2
An ultrastructural study of pale eumycetoma grains.
Sabouraudia. 1983 Dec;21(4):261-9. doi: 10.1080/00362178385380421.
3
The antigenic composition and protein profiles of eumycetoma agents.
Mycoses. 1991 Jan-Feb;34(1-2):19-28. doi: 10.1111/j.1439-0507.1991.tb00614.x.
4
Black grain mycetoma: the ultrastructure of Madurella mycetomi.
Mycopathologia. 1979 Mar 30;67(1):51-4. doi: 10.1007/BF00436241.
5
Studies on antigens from agents causing black grain eumycetoma.引起黑色颗粒状足菌肿病原体的抗原研究。
J Med Vet Mycol. 1989;27(5):303-11. doi: 10.1080/02681218980000411.
6
The ultrastructure of actinomycetoma grains caused by Streptomyces somaliensis.索马里链霉菌引起的足菌肿颗粒的超微结构
Am J Trop Med Hyg. 1987 Jul;37(1):174-9. doi: 10.4269/ajtmh.1987.37.174.
7
Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis.果糖-1,6-二磷酸醛缩酶和丙酮酸激酶,是枝顶孢霉中的两种新的免疫原。
Med Mycol. 2012 Feb;50(2):143-51. doi: 10.3109/13693786.2011.593005. Epub 2011 Jul 5.
8
Black grain mycetoma. A study of the chemistry, formation and significance of the tissue grain in Madurella mycetomi infection.黑色颗粒型足菌肿。马杜拉足菌肿感染中组织颗粒的化学、形成及意义的研究。
Br J Dermatol. 1974 Sep;91(3):297-303. doi: 10.1111/j.1365-2133.1974.tb12899.x.
9
Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole.白细胞对足菌肿病原体的趋化作用——抗真菌药物灰黄霉素和酮康唑的效应
Trans R Soc Trop Med Hyg. 1987;81(2):319-21. doi: 10.1016/0035-9203(87)90252-5.
10
Translationally controlled tumor protein from Madurella mycetomatis, a marker for tumorous mycetoma progression.来自马杜拉足分支菌病的翻译调控肿瘤蛋白,一种肿瘤性足分支菌病进展的标志物。
J Immunol. 2006 Aug 1;177(3):1997-2005. doi: 10.4049/jimmunol.177.3.1997.

引用本文的文献

1
In vitro susceptibility testing for black grain eumycetoma causative agents.体外药敏试验对黑色颗粒外瓶霉病致病因子。
Trans R Soc Trop Med Hyg. 2021 Apr 14;115(4):343-354. doi: 10.1093/trstmh/traa184.
2
Use of immunoblotting in testing Madurella mycetomatis specific antigen.免疫印迹法在检测马杜拉足分支菌特异性抗原中的应用。
Trans R Soc Trop Med Hyg. 2016 May;110(5):312-6. doi: 10.1093/trstmh/trw023.
3
A histopathological exploration of the Madurella mycetomatis grain.棘孢木层孔菌颗粒的组织病理学研究。
PLoS One. 2013;8(3):e57774. doi: 10.1371/journal.pone.0057774. Epub 2013 Mar 6.
4
Infections caused by Scedosporium spp.由瓶霉属真菌引起的感染
Clin Microbiol Rev. 2008 Jan;21(1):157-97. doi: 10.1128/CMR.00039-07.